176 related articles for article (PubMed ID: 16224050)
1. Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.
Urso ML; Clarkson PM; Hittel D; Hoffman EP; Thompson PD
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2560-6. PubMed ID: 16224050
[TBL] [Abstract][Full Text] [Related]
2. Effect of statins on skeletal muscle function.
Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Circulation; 2013 Jan; 127(1):96-103. PubMed ID: 23183941
[TBL] [Abstract][Full Text] [Related]
3. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.
Ballard KD; Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Atherosclerosis; 2013 Sep; 230(1):121-4. PubMed ID: 23958263
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system.
Sahebkar A; Cicero AFG; Di Giosia P; Pomilio I; Stamerra CA; Giorgini P; Ferri C; von Haehling S; Banach M; Jamialahmadi T
J Cachexia Sarcopenia Muscle; 2020 Oct; 11(5):1177-1186. PubMed ID: 32743965
[TBL] [Abstract][Full Text] [Related]
5. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.
Thompson PD; Parker BA; Clarkson PM; Pescatello LS; White CM; Grimaldi AS; Levine BD; Haller RG; Hoffman EP
Prev Cardiol; 2010; 13(3):104-11. PubMed ID: 20626664
[TBL] [Abstract][Full Text] [Related]
6. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.
Kearns AK; Bilbie CL; Clarkson PM; White CM; Sewright KA; O'Fallon KS; Gadarla M; Thompson PD
Atherosclerosis; 2008 Sep; 200(1):121-5. PubMed ID: 18261731
[TBL] [Abstract][Full Text] [Related]
7. No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study.
Panayiotou G; Paschalis V; Nikolaidis MG; Theodorou AA; Deli CK; Fotopoulou N; Fatouros IG; Koutedakis Y; Sampanis M; Jamurtas AZ
Scand J Med Sci Sports; 2013 Oct; 23(5):556-67. PubMed ID: 22288788
[TBL] [Abstract][Full Text] [Related]
8. A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.
Laaksonen R; Katajamaa M; Päivä H; Sysi-Aho M; Saarinen L; Junni P; Lütjohann D; Smet J; Van Coster R; Seppänen-Laakso T; Lehtimäki T; Soini J; Oresic M
PLoS One; 2006 Dec; 1(1):e97. PubMed ID: 17183729
[TBL] [Abstract][Full Text] [Related]
9. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
Chung J; Brass EP; Ulrich RG; Hiatt WR
Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
[TBL] [Abstract][Full Text] [Related]
10. STOMPing forward: statins, muscle complaints and CK.
Laaksonen R
Atherosclerosis; 2013 Oct; 230(2):256-7. PubMed ID: 24075753
[No Abstract] [Full Text] [Related]
11. Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link?
Famularo G; Minisola G; Gasbarrone L
Expert Opin Drug Saf; 2010 Nov; 9(6):1005-6; author reply 1006. PubMed ID: 20919802
[No Abstract] [Full Text] [Related]
12. [Statin therapy and muscle disorders].
Abel T; Fehér J
Orv Hetil; 2009 Feb; 150(6):261-3. PubMed ID: 19179258
[No Abstract] [Full Text] [Related]
13. Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy.
Skottheim IB; Bogsrud MP; Hermann M; Retterstøl K; Åsberg A
Mol Diagn Ther; 2011 Aug; 15(4):221-7. PubMed ID: 21815705
[TBL] [Abstract][Full Text] [Related]
14. Myopathy after switching from brand to generic atorvastatin.
Awoniyi O; Gosmanov AR
J Am Geriatr Soc; 2013 Dec; 61(12):2254-2255. PubMed ID: 24329838
[No Abstract] [Full Text] [Related]
15. Systemic infections can decrease the threshold of statin-induced muscle injury.
Mahboobi SK; Shohat EZ; Jellinek SP; Rose M
South Med J; 2006 Apr; 99(4):403-4. PubMed ID: 16634254
[No Abstract] [Full Text] [Related]
16. Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels.
Ann Intern Med; 2002 Oct; 137(7):I45. PubMed ID: 12353973
[No Abstract] [Full Text] [Related]
17. Mitochondria of trained skeletal muscle are protected from deleterious effects of statins.
Bouitbir J; Daussin F; Charles AL; Rasseneur L; Dufour S; Richard R; Piquard F; Geny B; Zoll J
Muscle Nerve; 2012 Sep; 46(3):367-73. PubMed ID: 22907227
[TBL] [Abstract][Full Text] [Related]
18. The effect of statins on skeletal muscle function: the STOMP trial.
Farmer JA
Curr Atheroscler Rep; 2013 Aug; 15(8):347. PubMed ID: 23843151
[No Abstract] [Full Text] [Related]
19. Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.
Newman C; Tsai J; Szarek M; Luo D; Gibson E
Am J Cardiol; 2006 Jan; 97(1):61-7. PubMed ID: 16377285
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin.
Brunham LR; Lansberg PJ; Zhang L; Miao F; Carter C; Hovingh GK; Visscher H; Jukema JW; Stalenhoef AF; Ross CJ; Carleton BC; Kastelein JJ; Hayden MR
Pharmacogenomics J; 2012 Jun; 12(3):233-7. PubMed ID: 21243006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
